Close Menu
NEW YORK (GenomeWeb News) – Asuragen said yesterday that it has raised $18.5 million in Series B financing.
 
The funding adds to $49 million that the company raised in a Series A round last year.
 
Investors in the Series B round include PTV Sciences, a new investor, as well as previous investors Telegraph Hill Partners and Growth Capital Partners.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.